A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Latest

Latest news, 22 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

Post-surgery atrial fibrillation rarely recurs, yet anticoagulation often continues: Swedish study

In 1,012 cardiac surgery patients at a Swedish centre, 43% developed postoperative AF, but documented AF during follow-up was only 8.8% at one year, while oral anticoagulants were often continued, raising concerns about overtreatment.

Medical Dialogues
DiabetologyDiabetology

Stopping GLP-1 receptor agonists linked to about twice the rate of MI, stroke or death in type 2 diabetes

In an Italian records study of 80,302 adults with type 2 diabetes, people who stopped GLP-1 receptor agonists had roughly double the rate of nonfatal MI, nonfatal stroke or death compared with matched persistent users.

News-Medical
NephrologyNephrology

NEJM trial: intermittent haemodialysis fails noninferiority to CRRT in critically ill patients with AKI

In a multicentre ICU trial of 554 patients with acute kidney injury, starting with intermittent haemodialysis was not noninferior to continuous renal replacement therapy for 90-day major adverse kidney events, and mortality was higher.

Medical Dialogues
NeurologyNeurology

Five-year Clarity AD extension data suggest lecanemab benefit in early Alzheimer disease keeps growing

Long-term extension data presented at CTAD 2026 showed that continuous lecanemab for five years was linked to slower decline on CDR-SB than in external natural-history cohorts, with ARIA-E becoming uncommon after the first year.

NeurologyLive
UrologyUrology

Waist and BMI linked to prostate enlargement and LUTS, especially in Asian men: meta-analysis

A European Urology systematic review of 24 studies tied higher waist circumference and BMI to benign prostatic enlargement and bothersome LUTS in Asian men, with lifestyle factors also implicated, though evidence certainty was very low.

European Urology
PsychiatryPsychiatry

Treating alcohol use disorder before cirrhosis saves money and lives in liver disease model

A JAMA Network Open economic model found that naltrexone for 16 weeks plus a year of counselling, started at F3 fibrosis in alcohol-associated liver disease, cut liver deaths and cirrhosis and lowered lifetime costs versus no treatment.

JAMA Network Open
PulmonologyPulmonology

Tirzepatide tied to fewer severe asthma attacks than tezepelumab in obesity-associated asthma

In an AJRCCM cohort of 2,779 non-diabetic adults with obesity-associated moderate-to-severe asthma, tirzepatide starters had a lower hazard of severe exacerbation than tezepelumab starters, while semaglutide performed similarly.

American Journal of Respiratory and Critical Care Medicine
Critical CareCritical Care

Centres favouring ICP-guided care show lower ICU mortality in severe TBI with unreactive pupils

A CENTER-TBI target trial emulation of 773 adults with severe traumatic brain injury found that treatment at centres more inclined to use ICP-guided management was associated with lower ICU mortality, most clearly when one or both pupils were unreactive.

Critical Care
GastroenterologyGastroenterology

Routine PPI with dual antiplatelet therapy after ischaemic stroke did not cut GI bleeding in study

In 3,122 Chinese patients with large-artery stroke on aspirin plus clopidogrel or ticagrelor, GI bleeding was 2.1% with a PPI and 1.3% without (adjusted OR 1.51, 95% CI 0.87-2.62), showing no clear protective effect.

Medical Dialogues
DermatologyDermatology

Real-world dupilumab in prurigo nodularis: 59% reach itch response by week 24 in small Spanish study

In 26 Spanish adults with chronic prurigo nodularis, 59% of evaluable patients had a 4-point or greater itch reduction at week 24; five of nine patients who extended dosing intervals stayed clear or almost clear.

Dermatology and Therapy
OphthalmologyOphthalmology

Systemic IL-6 inhibitor use linked to lower diabetic retinopathy risk in large US database study

In a matched TriNetX analysis of 2,605 diabetic adults on systemic IL-6 inhibitors versus controls, users had lower 5-year risks of NPDR, PDR (53% lower) and DME (63% lower); the authors say prospective trials are needed.

Medical Dialogues
ENTENT

Karnataka newborn hearing screening study finds deafness in about 4 per 1,000 infants screened

Among 10,254 newborns and infants screened with OAE at a Davangere teaching hospital over 4.5 years, 241 needed BERA and 42 had abnormal results, giving a deafness incidence of 4.095 per 1,000 screened.

Indian Journal of Otolaryngology and Head & Neck Surgery
OrthopaedicsOrthopaedics

Indian cohort on open long-bone fractures finds no significant effect of 6-hour debridement or lavage

In 83 adults with open long-bone fractures in eastern India, deep infection was numerically lowest with early debridement plus pulsatile lavage, but no primary outcome differed significantly; the authors call the results hypothesis-generating.

Indian Journal of Orthopaedics
GynaecologyGynaecology

ACOG urges routine bilateral salpingectomy at hysterectomy to lower ovarian cancer risk

ACOG's updated guidance says tubes should routinely be removed at hysterectomy, offered at other peritoneal gynaecological surgery when fertility is not wanted, and preferred for permanent contraception.

Medical Dialogues
PaediatricsPaediatrics

Febrile seizures alone not linked to poorer school test scores in Danish cohort of 672,119 children

In Danish national test data, children with a history of febrile seizures scored almost the same as peers; lower scores were seen mainly with many seizure-related hospital contacts or later epilepsy.

Medical Dialogues
SurgerySurgery

ARMMS-T2D: metabolic surgery gives lasting type 2 diabetes remission over a median 11 years

In 262 adults with type 2 diabetes, 58% assigned to metabolic-bariatric surgery were in remission at long-term follow-up versus 3% with intensive medical and lifestyle management.

Medical Dialogues
General MedicineGeneral Medicine

IVIG added to prednisone speeds and deepens response in newly diagnosed myositis: JAMA Neurology RCT

In a Dutch double-blind trial of 44 adults with new idiopathic inflammatory myopathy, IVIG plus prednisone gave major improvement at 12 weeks in 70% versus 26% with placebo plus prednisone.

Medical Dialogues
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team